| 伊伐布雷定在心血管疾病中的研究进展 |
| |
| 引用本文： | 李春雷.伊伐布雷定在心血管疾病中的研究进展[J].心血管病学进展,2012,33(3):327-330. |
| |
| 作者姓名： | 李春雷 |
| |
| 作者单位： | 哈尔滨医科大学附属第一医院心内科,黑龙江哈尔滨,150001 |
| |
| 摘 要： | 伊伐布雷定为首个特异性心脏起搏电流抑制剂,具有特异性降低心率的作用,相关的动物实验及大规模临床研究也日益增多。现对伊伐布雷定在心血管疾病中的研究进展进行综述。
|
| 关 键 词： | 伊伐布雷定 细胞 动物 临床 |
Advances in Using Ivabradine in Cardiovascular Disease |
| |
| LI Chun-lei.Advances in Using Ivabradine in Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2012,33(3):327-330. |
| |
| Authors: | LI Chun-lei |
| |
| Institution: | (Department of Cardiology,The First Affiliated Hospital of Harbin Medical University,Harbin 150001,Heilongjiang,China) |
| |
| Abstract: | Ivabradine is the first cardiac pacing current(If current) inhibitor that specifically reduces heart rate.To date,there have been numerous ivabradine-related animal experiments and large clinical trials.This article reviews advances in using ivabradine in cardiovascular disease. |
| |
| Keywords: | ivabradine cell animal clinic |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
